Industry ranking
From 2018 to 2023, the average time taken for PPD GLOBAL LTD to pay invoices to suppliers decreased from 56 days to 42 days. The percentage of invoices paid within 30 days also increased from 13% to 28%, while the percentage of invoices paid later than 60 days decreased from 46% to 11%. This suggests that the company has improved its payment processes and is paying invoices more promptly over time.
The average time taken to pay invoices for PPD GLOBAL LTD has varied between 32 days and 58 days over the past three years, with the largest change occurring in the first half of 2020 when it decreased by 13 days. The percentage of invoices paid within 30 days has also fluctuated, with a high of 47% in the second half of 2020 and a low of 17% in the second half of 2018. This indicates that the company's payment practices may not be consistent and can vary greatly from period to period.
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jul 2025 - 31 Dec 2025 | 05 May 2026 | 49 | 23% | 55% | 22% | 55% |
| 01 Jan 2025 - 30 Jun 2025 | 30 Jul 2025 | 52 | 20% | 54% | 26% | 58% |
| 01 Jul 2024 - 31 Dec 2024 | 18 Mar 2025 | 49 | 22% | 60% | 18% | 52% |
| 01 Jan 2024 - 30 Jun 2024 | 12 Aug 2024 | 45 | 25% | 59% | 16% | 48% |
| 01 Jul 2023 - 31 Dec 2023 | 30 Jan 2024 | 42 | 28% | 61% | 11% | 41% |
| 01 Jan 2023 - 30 Jun 2023 | 31 Jul 2023 | 44 | 30% | 56% | 14% | 33% |
| 01 Jul 2022 - 31 Dec 2022 | 30 Jan 2023 | 35 | 48% | 44% | 8% | 85% |
| 01 Jan 2022 - 30 Jun 2022 | 01 Sept 2022 | 37 | 42% | 51% | 7% | 94% |
| 01 Jul 2021 - 31 Dec 2021 | 31 Jan 2022 | 40 | 37% | 54% | 9% | 91% |
| 01 Jan 2021 - 30 Jun 2021 | 28 Jul 2021 | 32 | 42% | 50% | 8% | 91% |
| 01 Jul 2020 - 31 Dec 2020 | 29 Jan 2021 | 34 | 47% | 47% | 6% | 93% |
| 01 Jan 2020 - 30 Jun 2020 | 22 Jul 2020 | 47 | 22% | 62% | 16% | 98% |
| 01 Jul 2019 - 31 Dec 2019 | 30 Jan 2020 | 54 | 26% | 59% | 15% | 98% |
| 01 Jan 2019 - 30 Jun 2019 | 25 Jul 2019 | 51 | 34% | 48% | 18% | 96% |
| 01 Jul 2018 - 31 Dec 2018 | 28 Jan 2019 | 58 | 17% | 30% | 53% | 98% |
| 01 Jan 2018 - 30 Jun 2018 | 12 Jul 2018 | 56 | 13% | 41% | 46% | 97% |
This information is as reported by the business, and responses are in their own words.
Standard payment terms
PPD's standard payment terms are 60 days.
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
60
PPD has a dedicated Accounts Payable helpdesk that offers support to our suppliers to achieve resolution in the event of disputes or queries on invoice payment. The helpdesk team can be contacted by email on CentralAPTeam@ppd.com
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
PPD Global Ltd is registered in Cambridge and forms part of the PPD clinical research business, which operates within Thermo Fisher Scientific. The wider group works as a global contract research organisation, providing drug development, laboratory and lifecycle management services to pharmaceutical, biotechnology, medical device, academic and government customers. Its services span clinical development, biostatistics, clinical data management, pharmacovigilance, medical writing, regulatory affairs and bioanalytical, central and GMP laboratory testing, supporting the design, running and analysis of clinical trials. This entity represents the UK registered company within that international group structure, aligned with the SIC classification for research and experimental development in natural sciences and engineering.
Generated from the company's website and Companies House records. Sources: ppdi.com · ppdi.com